Isohomohalichondrin B
Alternative Names: IHB; IsohomohalicondiumLatest Information Update: 07 Oct 2004
At a glance
- Originator PharmaMar
- Class Antineoplastics; Pyrans; Spiro compounds
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Oct 2004 Discontinued - Preclinical for Cancer in Spain (unspecified route)
- 06 Sep 2002 This compound is still in active development
- 05 Sep 1996 Preclinical development for Cancer in Spain (Unknown route)